Dimorphic expression of cerebrosides in the mycopathogen Sporothrix schenckii

Journal of Lipid Research

Volumn 41, Issue 5, 2000, Pages 797-806

  Toledo, Marcos S ^a   Levery, Steven B ^b   Straus, Anita H ^a   Takahashi, Helio K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Georgia ^*  (United States)

Author keywords

Collision induced dissociation; Electrospray ionization; ES1 MS; Fungus; Mass spectrometry; Mycosis; NMR; Nuclear magnetic resonance spectroscopy; Tandem mass spectrometry; Yeast

Indexed keywords

BETA GALACTOPYRANOSYLCERAMIDE; BETA GLUCOPYRANOSYLCERAMIDE; CERAMIDE DERIVATIVE; CEREBROSIDE; SATURATED FATTY ACID; SPHINGOSINE DERIVATIVE; STEARIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ARTICLE; CELL WALL; CONTROLLED STUDY; FATTY ACID DESATURATION; MEMBRANE STRUCTURE; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII; STRUCTURE ANALYSIS; YEAST;

ANIMALS; CEREBROSIDES; GLYCOSPHINGOLIPIDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; SPOROTHRIX; SPOROTRICHOSIS;

EID: 0034111263     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Travassos, L. R. 1985. Sporothrix schenckii. In Fungal Dimorphism. P. J. Szaniszlo and J. L. Harris, editors. Plenum Press, New York and London. 121-163.
2. Szaniszlo, P. J., C. W. Jacobs, and P. A. Geis. 1983. Dimorphism: morphological and biochemical aspects. In Fungi Pathogenic for Humans and Animals. Part A. Biology. D. H. Howard and L. F. Howard, editors. Marcel Dekker, New York and Basel. 323-436.
3. Davis, B. A. 1996. Sporotrichosis. Dermatol. Clin. 14: 69-76.
4. Restrepo, A. 1994. Treatment of tropical mycoses. J. Am. Acad. Dermatol. 31: S91-102.
5. Rivitti, E. A., and V. Aoki. 1999. Deep fungal infections in tropical countries. Clin. Dermatol. 17: 171-190.
6. Mercurio, M. G., and B. E. Elewski. 1993. Therapy of sporotrichosis. Semin. Dermatol. 12: 285-289.
7. Dixon, D. M., M. M. McNeil, M. L. Cohen, B. G. Gellin, and M. J. La. 1996. Fungal infections: a growing threat. Public Health Rep. 111: 226-235.
8. Durden, F. M., and B. Elewski. 1997. Fungal infections in HIV-infected patients. Semin. Cutan. Med. Surg. 16: 200-212.
9. Lortholary, O., D. W. Denning, and B. Dupont. 1999. Endemic mycoses: a treatment update. J. Antimicrob. Chemother. 43: 321-331.
10. Ware, A. J., C. J. Cockerell, D. J. Skiest, and H. M. Kussman. 1999. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J. Am. Acad. Dermatol. 40: 350-355.
11. al-Tawfiq, J. A., and K. K. Wools. 1998. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin. Infect. Dis. 26: 1403-1406.
12. Chua, S. S., M. Momany, L. Mendoza, and P. J. Szaniszlo. 1994. Identification of three chitin synthase genes in the dimorphic fungal pathogen Sporothrix schenckii. Curr. Microbiol. 29: 151-156.
13. Travassos, L. R. 1989. Antigenic structures of Sporothrix schenckii. In Immunology of Fungal Diseases. E. Kurstak, G. Marquis, P. Auger, L. de Repentigny, and S. Montplaisir, editors. Marcel Dekker, Inc., New York. 193-221.
14. Daum, G., N. D. Lees, M. Bard, and R. Dickson. 1998. Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae [In Process Citation]. Yeast. 14: 1471-1510.
15. Dickson, R. C. 1998. Sphingolipid functions in Saccharomyces cerevisiae. comparison to mammals. Annu. Rev. Biochem. 67: 27-48.
16. Dickson, R. C., and R. L. Lester. 1999. Yeast sphingolipids. Biochim. Biophys. Acta. 1426: 347-357.
17. Merrill, A. H., Y. Hanunn, and R. M. Bell. 1993. Introduction: sphingolipids and their metabolites in cell regulation. Adv. Lipid Res. 25: 1-24.
18. Spiegel, S., A. Olivera, and R. O. Carlson. 1993. The role of sphingosine in cell growth regulation and transmembrane signaling. Adv. Lipid Res. 25: 105-129.
19. Mathias, S., L. A. Peña, and R. N. Kolesnick. 1998. Signal transduction of stress via ceramide. Biochem. J. 335: 405-480.
20. Hakomori, S. 1990. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265: 18713-18716.
21. Ladisch, S., B. Gillard, C. Wong, and L. Ulsh. 1983. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43: 3808-3813.
22. Ladisch, S., L. Ulsh, B. Gillard, and C. Wong. 1984. Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. J. Clin. Invest. 74: 2074-2081.
23. Ladisch, S., H. Becker, and L. Ulsh. 1992. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim. Biophys. Acta. 1125: 180-188.
24. Ladisch, S., R. Li, and E. Olson. 1994. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA. 91: 1974-1978.
25. Kawai, G., and Y. Ikeda. 1985. Structure of biologically active and inactive cerebrosides prepared from Schizophyllum commune. J. Lipid Res. 26: 338-343.
26. Kawai, G., and Y. Ikeda. 1983. Chemistry and functional moiety of a fruiting-inducing cerebroside in Schizophyllum commune. Biochim. Biophys. Acta. 754: 243-248.
27. Kawai, G., and Y. Ikeda. 1982. Fruiting-inducing activity of cerebrosides observed with Schizophyllum commune. Biochim. Biophys. Acta. 719: 612-618.
28. Kawai, G. 1989. Molecular species of cerebrosides in fruiting bodies of Lentinus edodes and their biological activity. Biochim. Biophys. Acta. 1001: 185-190.
29. Mizushina, Y., L. Hanashima, T. Yamaguchi, M. Takemura, F. Sugawara, M. Saneyoshi, A. Matsukage, S. Yoshida, and K. Sakaguchi. 1998. A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochim. Biophys. Res. Commun. 249: 17-22.
30. Kawai, G., Y. Ikeda, and K. Tubaki. 1985. Fruiting of Schizophyllum commune induced by certain ceramides and cerebrosides from Penicillium funiculosum. Agric. Biol. Chem. 49: 2137-2146.
31. Sitrin, R. D., G. Chan, J. Dingerdissen, C. DeBrosse, R. Mehta, G. Roberts, S. Rottschaefer, D. Staiger, J. Valenta, K. M. Snader, R. J. Stedman, and J. R. E. Hoover. 1988. Isolation and structure determination of Pachybasium cerebrosides which potentiate the anti-fungal activity of aculeacin. J. Antibiot. (Tokyo) 41: 469-480.
32. Koga, J., T. Yamauchi, M. Shimura, N. Ogawa, K. Oshima, K. Umemura, M. Kikuchi, and N. Ogasawara. 1998. Cerebrosides A and C, sphingolipid elicitors of hypersensitive cell death and phytoalexin accumulation in rice plants. J. Biol. Chem. 273: 31985-31991.
33. 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. Biochemistry. 38: 7294-7306.
34. Levery, S. B., M. S. Toledo, A. H. Straus, and H. K. Takahashi. 1998. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant β-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. Biochemistry. 37: 8764-8775.
35. Toledo, M. S., E. Suzuki, A. H. Straus, and H. K. Takahashi. 1995. Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. J. Med. Vet. Mycol. 33: 247-201.
36. Sweeley, C. C. 1969. Chromatography on columns of silica gel. Methods Enzymol. 14: 254-267.
37. 1H nuclear magnetic resonance spectroscopy. Biochemistry. 19: 5652-5658.
38. 1H-NMR studies on glycosphingolipids. Biochim. Biophys. Acta. 618: 473-479.
39. 13C NMR analysis of galactosylceramides. Chem. Phys. Lipid. 26: 187-196.
40. Villas Boas, M. H., H. Egge, G. Pohlentz, R. Hartmann, and E. B. Bergter. 1994. Structural determination of N-2′-hydroxyoctadecenoyl-1-O-beta-D-glucopyranosyl-9-methyl-4,8- sphingadienine from species of Aspergillus. Chem. Phys. Lipids. 70: 11-19.
41. Cardoso, D. B. S., J. Angluster, L. R. Travassos, and C. S. Alviano. 1987. Isolation and characterization of a glucocerebroside (monoglucosylceramide) from Sporothrix schenckii. FEMS Microbiol. Lett. 43: 279-282.
42. Matsubara, T., A. Hayashi, Y. Banno, T. Morita, and Y. Nozawa. 1987. Cerebroside of the dimorphic human pathogen, Candida albicans. Chem. Phys. Lipids. 43: 1-12.
43. Wells, G. B., R. C. Dickson, and R. L. Lester. 1996. Isolation and composition of inositolphosphorylceramide-type sphingolipids of hyphal forms of Candida albicans. J. Bacteriol. 178: 6223-6226.
44. Barr, K., and R. L. Lester. 1984. Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum. Biochemistry. 23: 5581-5588.
45. Barr, K., R. A. Laine, and R. L. Lester. 1984. Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry. 23: 5589-5596.
46. Nagiec, M. M., E. E. Nagiec, J. A. Baltisberger, G. B. Wells, R. L. Lester, and R. C. Dickson. 1997. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J. Biol. Chem. 272: 9809-9817.
47. Hannun, Y., L. M. Obeid, and R. M. Wolff. 1993. The novel second messenger ceramide: Identification, mechanism of action, and cellular activity. Adv. Lipid Res. 25: 43-64.
48. Hakomori, S. 1996. Sphingolipid-dependent protein kinases. Adv. Pharmacol. 36: 155-171.
49. Hakomori, S., and Y. Igarashi. 1993. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv. Carbohydr. Chem. 25: 147-162.
50. Villalobo, A., and H-J. Gabius. 1998. Signaling pathways for transduction of the initial message of the glycocode into cellular responses. Acta Anat. 161: 110-129.
51. Dobrowsky, R. T., and Y. A. Hannun. 1993. Ceramide-activated protein phosphatase: Partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 25: 91-104.
52. Kolter, T., and K. Sandhoff. 1999. Sphingolipids - their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew. Chem. Intl. Ed. Engl. 38: 1532-1568.
53. Anderson, R. G. W. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
54. Lichter, A., and D. Mills. 1997. Fill, a G-protein alpha-subunit that acts upstream of cAMP and is essential for dimorphic switching in haploid cells of Ustilago hordei. Mol. Gen. Genet. 256: 426-435.
55. Roberts, R. L., and G. R. Fink. 1994. Elements of a single MAP kinase cascade in Saccharomyces cerevisiae mediate two developmental programs in the same cell type: mating and invasive growth. Genes Dev. 8: 2974-2985.
56. Gow, N. A. 1997. Germ tube growth of Candida albicans. Curr. Top. Med. Mycol. 8: 43-55.
57. Banuett, F., and I. Herskowitz. 1994. Identification of fuz7, a Ustilago maydis MEK/MAPKK homolog required for a-locus-dependent and -independent steps in the fungal life cycle. Genes Dev. 8: 1367-1378.
58. Roze, L. V., and J. E. Linz. 1998. Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus. Fungal. Genet. Biol. 25: 119-133.
59. Yaar, L., M. Mevarech, and Y. Koltin. 1997. A Candida albicans RAS-related gene (CaRSR1) is involved in budding, cell morphogenesis and hypha development. Microbiology. 143: 3033-3044.
60. Diez-Orejas, R., G. Molero, F. Navarro-Garcia, J. Pla, C. Nombela, and M. Sanchez-Perez. 1997. Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect. Immun. 65: 833-837.
61. Aquino-Pinero, E. E., and N. Rodriguez del Valle. 1997. Different protein kinase C isoforms are present in the yeast and mycelium forms of Sporothrix schenckii. Mycopathologia. 138: 109-115.
62. Kannagi, R., S. B. Levery, and S. Hakomori. 1983. Sequential change of carbohydrate antigen associated with differentiation of marine leukemia cells: i-I antigenic conversion and shifting of glycolipid synthesis. Proc. Natl. Acad. Sci. USA. 80: 2844-2848.
63. Straus, A. H., S. B. Levery, M. G., Jasiulionis, M. K. Salyan, S. J. Steele, L. R. Travassos, S. Hakomori, and H. K. Takahashi. 1993. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J. Biol. Chem. 268: 13723-13730.
64. Suzuki, E., M. S. Toledo, H. K. Takahashi, and A. H. Straus. 1997. A monoclonal antibody directed to terminal residue of β-galactofuranose of a glycolipid antigen isolated from Paracoccidioides brasiliensis: cross-reactivity with Leishmania major and Trypanosoma cruzi. Glycobiology. 7: 463-468.
65. Lester, R. L., and R. C. Dickson. 1993. Sphingolipids with inositol-phosphate-containing head groups. Adv. Lipid Res. 26: 253-274.
66. 2+ concentrations at 37°C, is required for mannosylation of inositolphosphoryl-ceramide. Mol. Gen. Genet. 255: 570-579.
67. Wagner, H., and W. Zofcsik. 1966. On new sphingolipids of yeast. Biochem. Z. 344: 314-316.
68. Tyorinoja, K., T. Nurminen, and H. Suomalainen. 1974. The cell-envelope glycolipids of baker's yeast. Biochem. J. 141: 133-139.
69. Nurminen, T., and H. Suomalainen. 1971. Occurrence of long-chain fatty acids and glycolipids in the cell envelope fractions of baker's yeast. Biochem. J. 125: 963-969.
70. Kang, M. S., J. P. Spencer, and A. D. Elbein. 1979. The effect of showdomycin on glycolipid formation. Inhibition of glucosylphosphoryl-dolichol in aorta and stimulation of glucosylceramide in yeast. J. Biol. Chem. 254: 10037-10043.
71. Ghannoum, M. A., G. J. Janini, L. Khamis, and S. S. Radwan. 1986. Dimorphism-associated variations in the lipid composition of Candida albicans. J. Gen. Microbiol. 132: 2367-2375.
72. Marriott, M. S. 1975. Isolation and chemical characterization of plasma membranes from the yeast and mycelial forms of Candida albicans. J. Gen. Microbiol. 86: 115-132.
73. Yamashita, T., R. Wada, T. Sasaki, C. Deng, U. Bierfreund, K. Sandhoff, and R. L. Proia. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. USA. 96: 9142-91-47.
74. Coetzee, T., N. Fujita, J. Dupree, R. Shi, A. Blight, K. Suzuki, and B. Popko. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell. 86: 209-219.
75. Bosio, A., E. Binczek, and W. Stoffel. 1996. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. USA. 93: 13280-13285.
76. Perry, K., and Y. A. Hannun. 1999. The role of ceramide in cell signaling. Biochim. Biophys. Acta. 1436: 233-243.